<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03177330</url>
  </required_header>
  <id_info>
    <org_study_id>201704033RIND</org_study_id>
    <nct_id>NCT03177330</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Heparin Dosing Score Protocol for Polymyxin-B Hemoperfusion</brief_title>
  <official_title>Safety and Efficacy of Heparin Dosing Score Protocol for Anticoagulation During Polymyxin-B Hemoperfusion: a Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Polymyxin B hemoperfusion (PMX-HP) is mainly used to remove endotoxins in septic shock
      patients with intra-abdominal infections. Because of the concerns of postoperative bleeding,
      physicians may hesitate to use anticoagulation in patients with septic shock within a few
      hours after an abdominal operation. We developed a heparin dosing score protocol for heparin
      dosage adjustment. The purpose of the study is to examine the safety and efficacy of the
      heparin dosing score protocol.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 15, 2017</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>premature cartridge clotting rate</measure>
    <time_frame>2 hours</time_frame>
    <description>the incidence of premature cartridge clotting within 2hr</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>bleeding event rate</measure>
    <time_frame>24 hours</time_frame>
    <description>the incidence of substantial bleeding event within 24hr</description>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Septic Shock</condition>
  <condition>Polymyxin B Hemoperfusion</condition>
  <eligibility>
    <study_pop>
      <textblock>
        intra-abdominal septic shock patients or documented Gram-negative bacterial septic shock
        patients who received polymyxin-B hemoperfusion
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  intra-abdominal septic shock patients or documented Gram-negative bacterial septic
             shock patients who received polymyxin-B hemoperfusion in National Taiwan University
             Hospital during October 2013-December 2016

        Exclusion Criteria:

          -  pregnant woman

          -  patients with do-not-resuscitate declaration

          -  uncontrolled bleeding within 24hr
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chen-Tse Lee, MD</last_name>
    <phone>+886972653169</phone>
    <email>lctbrian314@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesiology, NTUH, Taipei, Taiwan</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chen-Tse Lee, M.D.</last_name>
      <phone>+886-2-23123456</phone>
      <phone_ext>62158</phone_ext>
      <email>lctbrian314@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Chen-Tse Lee, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 4, 2017</study_first_submitted>
  <study_first_submitted_qc>June 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2017</study_first_posted>
  <last_update_submitted>June 5, 2017</last_update_submitted>
  <last_update_submitted_qc>June 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heparin</mesh_term>
    <mesh_term>Polymyxins</mesh_term>
    <mesh_term>Polymyxin B</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

